This review addresses the state of the literature on health-related quality
of life (HRQL) assessment among patients with cancers of the pancreas and
stomach. We first briefly review the epidemiology of these cancers. We exam
ine the concept of HRQL and the degree to which it has been measured among
these patient groups. The impact of gastric and pancreatic cancers on HRQL
is described, including the domains which these conditions are most likely
to impact. The effect of different treatments on HRQL is considered, includ
ing surgical procedures, pharmacological and nonpharmacological therapies,
and procedures for symptom palliation. Based on our findings on the limited
quantity and quality of the body of literature, we make suggestions for fu
rther research in the area.
Results suggest three areas in which HRQL can play an important role in the
study of gastric and pancreatic cancer. First, future investigations shoul
d consider both survival and HRQL in comparing surgical procedures. Second,
studies of chemotherapy should include HRQL evaluation, with careful atten
tion to conducting assessments at times appropriate to capture the effects
of chemotherapy. Third, studies of the impact of palliative care should inc
lude assessments of HRQL.